Treatment with interleukin-12/23p40 antibody attenuates acute cardiac allograft rejection

Transplantation

Volumn 91, Issue 1, 2011, Pages 27-34

  Xie, Aini ^a   Wang, Sihua ^a   Zhang, Kailun ^a   Wang, Guohua ^a   Ye, Ping ^a   Li, Jun ^a   Chen, Wenhao ^b   Xia, Jiahong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Allograft rejection; Heart transplantation; Monoclonal antibody; P40 subunit

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 17; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY P40; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CARDIAC GRAFT REJECTION; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HEART GRAFT; HEART MUSCLE CONTRACTILITY; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; ISOGRAFT; LYMPHOCYTE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TH1 CELL; TH17 CELL;

ACUTE DISEASE; ANIMALS; ANTIBODIES, MONOCLONAL; CYTOKINES; DOWN-REGULATION; GRAFT REJECTION; HEART TRANSPLANTATION; INTERLEUKIN-12 SUBUNIT P40; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MYOCARDIUM; SPLEEN; TH1 CELLS; TH17 CELLS; TRANSCRIPTION FACTORS; TREATMENT OUTCOME;

EID: 78751648202     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181fdd948     Document Type: Article

References (40)

1. Miniati DN, Robbins RC. Heart transplantation: A thirty-year perspective. Annu Rev Med 2002;53:189.
2. Christie JD, Edwards LB, Aurora P, et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Lung and Heart-Lung Transplantation Report-2009. J Heart Lung Transplant 2009;28:1031.
3. Valantine H. Cardiac allograft vasculopathy after heart transplantation: Risk factors and management. J Heart Lung Transplant 2004;23(5 suppl): S187.
4. Ingulli E. Mechanism of cellular rejection in transplantation. Pediatr Nephrol 2010;25:61.
5. Yin D, Fathman CG. CD4-positive suppressor cells block allotransplant rejection. J Immunol 1995;154:6339.
6. Shizuru JA, Seydel KB, Flavin TF, et al. Induction of donor-specific unresponsiveness to cardiac allografts in rats by pretransplant anti-CD4 monoclonal antibody therapy. Transplantation 1990;50:366.
7. Pietra BA, Wiseman A, Bolwerk A, et al. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II. J Clin Invest 2000;106:1003.
8. Atalar K, Afzali B, Lord G, et al. Relative roles of Th1 and Th17 effector cells in allograft rejection. Curr Opin Organ Transplant 2009;14:23.
9. Waaga AM, Gasser M, Kist-van Holthe JE, et al. Regulatory functions of self-restricted MHC class II allopeptide-specific Th2 clones in vivo. J Clin Invest 2001;107:909.
10. Shatry A, Chirinos J, Gorin MA, et al. Targeting Treg cells in situ: Emerging expansion strategies for (CD4 (+) CD25 (+)) regulatory T cells. Biol Blood Marrow Transplant 2009;15:1239.
11. Manetti R, Parronchi P, Giudizi MG, et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 1993;177:1199.
12. Oppmann B, Lesley R, Blom B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000;13:715.
13. Cornelissen F, van Hamburg JP, Lubberts E. The IL-12/IL-23 axis and its role in Th17 cell development, pathology and plasticity in arthritis. Curr Opin Investig Drugs 2009;10:452.
14. Wakashin H, Hirose K, Iwamoto I, et al. Role of IL-23-Th17 cell axis in allergic airway inflammation. Int Arch Allergy Immunol 2009;149(suppl 1):108.
15. Cua DJ, Sherlock J, Chen Y, et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003;421:744.
16. Bai A, Lu N, Guo Y, et al. All-trans retinoic acid down-regulates inflammatory responses by shifting the Treg/Th17 profile in human ulcerative and murine colitis. J Leukoc Biol 2009;86:959.
17. Gandhi M, Alwawi E, Gordon KB. Anti-p40 antibodies ustekinumab and briakinumab: Blockade of interleukin-12 and interleukin-23 in the treatment of psoriasis. Semin Cutan Med Surg 2010;29:48.
18. Brok HP, van Meurs M, Blezer E, et al. Prevention of experimental autoimmune encephalomyelitis in common marmosets using an anti-IL-12p40 monoclonal antibody. J Immunol 2002;169:6554.
19. Kato K, Shimozato O, Hoshi K, et al. Local production of the p40 subunit of interleukin 12 suppresses T-helper 1-mediated immune responses and prevents allogeneic myoblast rejection. Proc Natl Acad Sci USA 1996;93:9085.
20. Klebe S, Coster DJ, Sykes PJ, et al. Prolongation of sheep corneal allograft survival by transfer of the gene encoding ovine IL-12-p40 but not IL-4 to donor corneal endothelium. J Immunol 2005;175:2219.
21. Hunter CA. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol 2005;5:521.
22. Sakaguchi S, Wing K, Yamaguchi T. Dynamics of peripheral tolerance and immune regulation mediated by Treg. Eur J Immunol 2009;39:2331.
23. Apostolou I, Verginis P, Kretschmer K, et al. Peripherally induced Treg: Mode, stability, and role in specific tolerance. J Clin Immunol 2008;28:619.
24. Gately MK, Desai BB, Wolitzky AG, et al. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J Immunol 1991;147:874.
25. Hall BM. Cells mediating allograft rejection. Transplantation 1991;51:1141.
26. Elliott M, Ugai S, Chiyo M, et al. The secreted form of the p40 subunit of interleukin-12/23p40 in immune-mediated diseases. Immunology 2006;117:22.
27. Gillessen S, Carvajal D, Ling P, et al. Mouse interleukin-12 (IL-12) p40 homodimer: A potent IL-12 antagonist. Eur J Immunol 1995;25:200.
28. Yasuda H, Nagata M, Arisawa K, et al. Local expression of immunoregulatory IL-12p40 gene prolonged syngeneic islet graft survival in diabetic NOD mice. J Clin Invest 1998;102:1807.
29. Gunsten S, Mikols CL, Grayson MH, et al. IL-12 p80-dependent macrophage recruitment primes the host for increased survival following a lethal respiratory viral infection. Immunology 2009;126:500.
30. Piccotti JR, Chan SY, Goodman RE, et al. IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity. J Immunol 1996;157:1951.
31. Cooper AM, Khader SA. IL-12p40: An inherently agonistic cytokine. Trends Immunol 2007;28:33.
32. Mikols CL, Yan L, Norris JY, et al. IL-12 p80 is an innate epithelial cell effector that mediates chronic allograft dysfunction. Am J Respir Crit Care Med 2006;174:461.
33. Koizumi H, Konoeda Y, Kobayashi S, et al. Comparison of methods to evaluate acute rejection in heterotopic heart transplantation in rats. Exp Anim 1996;45:217.
34. Ha SJ, Lee CH, Lee SB, et al. A novel function of IL-12p40 as a chemotactic molecule for macrophages. J Immunol 1999;163:2902.
35. Walter MJ, Kajiwara N, Karanja P, et al. Interleukin 12 p40 production by barrier epithelial cells during airway inflammation. J Exp Med 2001;193:339.
36. Jana M, Dasgupta S, Saha RN, et al. Induction of tumor necrosis factor-alpha (TNF-alpha) by interleukin-12 p40 monomer and homodimer in microglia and macrophages. J Neurochem 2003;86:519.
37. Doenst T, Schlensak C, Kobba JL, et al. A technique of heterotopic, infrarenal heart transplantation with double anastomosis in mice. J Heart Lung Transplant 2001;20:762.
38. Cooper JD, Billingham M, Egan T, et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant 1993;12:713.
39. Shimizu K, Schönbeck U, Mach F, et al. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis. J Immunol 2000;165:3506.
40. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T)) Method. Methods 2001;25:402.